US Stock MarketDetailed Quotes

KRYS Krystal Biotech

Watchlist

201.580
+4.060+2.06%

Close Aug 23 16:00 ET

201.580
0.0000.00%

Post 19:18 ET

5.79BMarket Cap51.03P/E (TTM)

Krystal Biotech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

87.81%-4.17M

160.74%15.89M

11.70%-88.8M

67.61%-7.23M

-7.81%-21.23M

20.60%-34.19M

-68.82%-26.16M

-109.79%-100.57M

-6.84%-22.33M

-171.37%-19.69M

Net income from continuing operations

146.88%15.57M

102.06%932K

107.81%10.93M

127.12%8.69M

370.51%80.75M

-18.15%-33.21M

9.34%-45.3M

-101.20%-139.98M

-46.99%-32.05M

-91.47%-29.85M

Operating gains losses

-4.11%-1.65M

-49.94%-1.21M

-138,951.39%-99.97M

-46.00%27K

---97.61M

---1.58M

---809K

--72K

--50K

----

Depreciation and amortization

36.74%2.02M

22.73%1.61M

89.44%5.01M

854.80%2.44M

-122.56%-220K

51.43%1.48M

29.16%1.31M

42.94%2.64M

-137.50%-323K

24.52%975K

Other non cash items

567.35%327K

-23,900.00%-238K

-134.90%-451K

11,896.88%3.84M

-7,382.76%-4.34M

258.06%49K

100.74%1K

-118.50%-192K

113.91%32K

45.79%-58K

Change In working capital

-181.74%-33.29M

-28.45%6.3M

-1,447.63%-37.88M

-5,879.30%-25.71M

-5,685.98%-9.16M

50.94%-11.82M

-67.58%8.81M

12.17%2.81M

91.03%-430K

-95.89%164K

-Change in receivables

---56.77M

---4.43M

---42.04M

---32.72M

---9.32M

--0

----

-Change in inventory

158.50%530K

---2.24M

---4.48M

---492K

---3.08M

---906K

--0

----

-Change in prepaid assets

-333.65%-2.27M

-109.52%-264K

-191.96%-908K

42.55%-771K

179.78%512K

-1,967.86%-523K

-115.37%-126K

54.99%-311K

22.38%-1.34M

155.79%183K

-Change in payables and accrued expense

340.64%24.86M

46.29%13.38M

166.24%10.43M

598.77%8.52M

1,450.50%3.1M

56.89%-10.33M

-65.44%9.14M

14.69%3.92M

139.53%1.22M

-95.44%200K

-Change in other current assets

-114.74%-23K

213.04%52K

57.33%-64K

86.55%-16K

-243.48%-158K

2,500.00%156K

-611.11%-46K

-330.77%-150K

-283.08%-119K

---46K

-Change in other current liabilities

277.21%381K

-20.61%-199K

-28.13%-829K

-20.21%-226K

-28.90%-223K

-34.38%-215K

-30.95%-165K

-127.02%-647K

-317.78%-188K

-166.15%-173K

Cash from discontinued investing activities

Operating cash flow

87.81%-4.17M

160.74%15.89M

11.70%-88.8M

67.61%-7.23M

-7.81%-21.23M

20.60%-34.19M

-68.82%-26.16M

-109.79%-100.57M

-6.84%-22.33M

-171.37%-19.69M

Investing cash flow

Cash flow from continuing investing activities

-21.28%-19.35M

-829.16%-25.98M

172.44%82.64M

-95.08%-10.16M

813.50%105.19M

58.25%-15.96M

106.37%3.56M

49.69%-114.08M

95.88%-5.21M

60.33%-14.74M

Net PPE purchase and sale

59.46%-1.13M

76.58%-1.26M

77.73%-11.8M

64.60%-1.85M

87.33%-1.78M

83.11%-2.79M

68.70%-5.38M

22.47%-52.98M

87.24%-5.22M

33.04%-14.06M

Net investment purchase and sale

-38.39%-18.22M

-376.39%-24.72M

90.90%-5.56M

-92,466.67%-8.31M

1,114.99%6.97M

39.35%-13.17M

123.10%8.94M

61.43%-61.1M

100.01%9K

95.75%-687K

Net other investing changes

----

--100M

--0

----

Cash from discontinued investing activities

Investing cash flow

-21.28%-19.35M

-829.16%-25.98M

172.44%82.64M

-95.08%-10.16M

813.50%105.19M

58.25%-15.96M

106.37%3.56M

49.69%-114.08M

95.88%-5.21M

60.33%-14.74M

Financing cash flow

Cash flow from continuing financing activities

-94.26%10.64M

617.98%10.58M

473.60%202.75M

-14.66%2.62M

531.51%13.39M

503.48%185.27M

371.96%1.47M

-89.83%35.35M

-98.48%3.07M

40.58%2.12M

Net common stock issuance

----

465.34%203.5M

-14.66%2.62M

1,835.94%41.04M

----

-89.88%36M

-98.48%3.07M

40.58%2.12M

Proceeds from stock option exercised by employees

-58.17%10.64M

618.35%15.97M

----

--25.43M

--2.22M

----

Net other financing activities

--0

-619.09%-5.39M

-15.41%-749K

--0

-15.41%-749K

91.85%-649K

--0

Cash from discontinued financing activities

Financing cash flow

-94.26%10.64M

617.98%10.58M

473.60%202.75M

-14.66%2.62M

531.51%13.39M

503.48%185.27M

371.96%1.47M

-89.83%35.35M

-98.48%3.07M

40.58%2.12M

Net cash flow

Beginning cash position

155.08%359.01M

121.33%358.33M

-52.56%161.9M

100.23%373.24M

26.13%275.88M

-47.74%140.75M

-52.56%161.9M

27.20%341.25M

-34.96%186.41M

-33.63%218.72M

Current changes in cash

-109.53%-12.88M

102.32%491K

209.64%196.58M

39.62%-14.77M

401.30%97.35M

367.13%135.12M

70.64%-21.12M

-345.70%-179.31M

-144.79%-24.47M

24.71%-32.31M

Effect of exchange rate changes

-4,312.50%-337K

619.44%187K

-280.49%-156K

-241.46%-140K

--12K

--8K

---36K

---41K

--0

End cash Position

25.34%345.79M

155.08%359.01M

121.33%358.33M

100.23%373.24M

26.13%275.88M

-47.74%140.75M

-52.56%161.9M

-34.96%186.41M

Free cash flow

85.67%-5.3M

146.38%14.63M

34.48%-100.6M

67.04%-9.08M

31.82%-23.01M

37.93%-36.98M

3.51%-31.54M

-32.06%-153.55M

55.41%-27.55M

-19.46%-33.74M

Currency Unit

USD

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	87.81%-4.17M	160.74%15.89M	11.70%-88.8M	67.61%-7.23M	-7.81%-21.23M	20.60%-34.19M	-68.82%-26.16M	-109.79%-100.57M	-6.84%-22.33M	-171.37%-19.69M
Net income from continuing operations	146.88%15.57M	102.06%932K	107.81%10.93M	127.12%8.69M	370.51%80.75M	-18.15%-33.21M	9.34%-45.3M	-101.20%-139.98M	-46.99%-32.05M	-91.47%-29.85M
Operating gains losses	-4.11%-1.65M	-49.94%-1.21M	-138,951.39%-99.97M	-46.00%27K	---97.61M	---1.58M	---809K	--72K	--50K	----
Depreciation and amortization	36.74%2.02M	22.73%1.61M	89.44%5.01M	854.80%2.44M	-122.56%-220K	51.43%1.48M	29.16%1.31M	42.94%2.64M	-137.50%-323K	24.52%975K
Other non cash items	567.35%327K	-23,900.00%-238K	-134.90%-451K	11,896.88%3.84M	-7,382.76%-4.34M	258.06%49K	100.74%1K	-118.50%-192K	113.91%32K	45.79%-58K
Change In working capital	-181.74%-33.29M	-28.45%6.3M	-1,447.63%-37.88M	-5,879.30%-25.71M	-5,685.98%-9.16M	50.94%-11.82M	-67.58%8.81M	12.17%2.81M	91.03%-430K	-95.89%164K
-Change in receivables	---56.77M	---4.43M	---42.04M	---32.72M	---9.32M	--0	--0	--0	--0	----
-Change in inventory	158.50%530K	---2.24M	---4.48M	---492K	---3.08M	---906K	--0	--0	--0	----
-Change in prepaid assets	-333.65%-2.27M	-109.52%-264K	-191.96%-908K	42.55%-771K	179.78%512K	-1,967.86%-523K	-115.37%-126K	54.99%-311K	22.38%-1.34M	155.79%183K
-Change in payables and accrued expense	340.64%24.86M	46.29%13.38M	166.24%10.43M	598.77%8.52M	1,450.50%3.1M	56.89%-10.33M	-65.44%9.14M	14.69%3.92M	139.53%1.22M	-95.44%200K
-Change in other current assets	-114.74%-23K	213.04%52K	57.33%-64K	86.55%-16K	-243.48%-158K	2,500.00%156K	-611.11%-46K	-330.77%-150K	-283.08%-119K	---46K
-Change in other current liabilities	277.21%381K	-20.61%-199K	-28.13%-829K	-20.21%-226K	-28.90%-223K	-34.38%-215K	-30.95%-165K	-127.02%-647K	-317.78%-188K	-166.15%-173K
Cash from discontinued investing activities
Operating cash flow	87.81%-4.17M	160.74%15.89M	11.70%-88.8M	67.61%-7.23M	-7.81%-21.23M	20.60%-34.19M	-68.82%-26.16M	-109.79%-100.57M	-6.84%-22.33M	-171.37%-19.69M
Investing cash flow
Cash flow from continuing investing activities	-21.28%-19.35M	-829.16%-25.98M	172.44%82.64M	-95.08%-10.16M	813.50%105.19M	58.25%-15.96M	106.37%3.56M	49.69%-114.08M	95.88%-5.21M	60.33%-14.74M
Net PPE purchase and sale	59.46%-1.13M	76.58%-1.26M	77.73%-11.8M	64.60%-1.85M	87.33%-1.78M	83.11%-2.79M	68.70%-5.38M	22.47%-52.98M	87.24%-5.22M	33.04%-14.06M
Net investment purchase and sale	-38.39%-18.22M	-376.39%-24.72M	90.90%-5.56M	-92,466.67%-8.31M	1,114.99%6.97M	39.35%-13.17M	123.10%8.94M	61.43%-61.1M	100.01%9K	95.75%-687K
Net other investing changes	----	----	--100M	--0	----	----	----	----	----	----
Cash from discontinued investing activities
Investing cash flow	-21.28%-19.35M	-829.16%-25.98M	172.44%82.64M	-95.08%-10.16M	813.50%105.19M	58.25%-15.96M	106.37%3.56M	49.69%-114.08M	95.88%-5.21M	60.33%-14.74M
Financing cash flow
Cash flow from continuing financing activities	-94.26%10.64M	617.98%10.58M	473.60%202.75M	-14.66%2.62M	531.51%13.39M	503.48%185.27M	371.96%1.47M	-89.83%35.35M	-98.48%3.07M	40.58%2.12M
Net common stock issuance	----	----	465.34%203.5M	-14.66%2.62M	1,835.94%41.04M	----	----	-89.88%36M	-98.48%3.07M	40.58%2.12M
Proceeds from stock option exercised by employees	-58.17%10.64M	618.35%15.97M	----	----	----	--25.43M	--2.22M	----	----	----
Net other financing activities	--0	-619.09%-5.39M	-15.41%-749K	--0	--0	--0	-15.41%-749K	91.85%-649K	--0	--0
Cash from discontinued financing activities
Financing cash flow	-94.26%10.64M	617.98%10.58M	473.60%202.75M	-14.66%2.62M	531.51%13.39M	503.48%185.27M	371.96%1.47M	-89.83%35.35M	-98.48%3.07M	40.58%2.12M
Net cash flow
Beginning cash position	155.08%359.01M	121.33%358.33M	-52.56%161.9M	100.23%373.24M	26.13%275.88M	-47.74%140.75M	-52.56%161.9M	27.20%341.25M	-34.96%186.41M	-33.63%218.72M
Current changes in cash	-109.53%-12.88M	102.32%491K	209.64%196.58M	39.62%-14.77M	401.30%97.35M	367.13%135.12M	70.64%-21.12M	-345.70%-179.31M	-144.79%-24.47M	24.71%-32.31M
Effect of exchange rate changes	-4,312.50%-337K	619.44%187K	-280.49%-156K	-241.46%-140K	--12K	--8K	---36K	---41K	---41K	--0
End cash Position	25.34%345.79M	155.08%359.01M	121.33%358.33M	121.33%358.33M	100.23%373.24M	26.13%275.88M	-47.74%140.75M	-52.56%161.9M	-52.56%161.9M	-34.96%186.41M
Free cash flow	85.67%-5.3M	146.38%14.63M	34.48%-100.6M	67.04%-9.08M	31.82%-23.01M	37.93%-36.98M	3.51%-31.54M	-32.06%-153.55M	55.41%-27.55M	-19.46%-33.74M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall